Dahan Michel (CIK 0001669737)

Latest company ownership

Shares held
672,092
Last filed at
May 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 13, 2024 May 14, 2024 Akebia Therapeutics, Inc. COO Sell 41.3 -34,840 -4.93% ✓ $43.9K
Feb 29, 2024 Mar 1, 2024 Akebia Therapeutics, Inc. COO Sell 46.3 -8,661 -1.21% ✗ $13.7K
Feb 27, 2024 Feb 29, 2024 Akebia Therapeutics, Inc. COO Sell 46.3 -10,744 -1.48% ✗ $16.3K
May 24, 2023 May 25, 2023 Akebia Therapeutics, Inc. COO Sell 95.0 +104,522 22.26% ✗ $116.8K
Mar 1, 2023 Mar 3, 2023 Akebia Therapeutics, Inc. COO Sell 46.3 -20,412 -7.04% ✗ $17.9K
Feb 27, 2023 Mar 1, 2023 Akebia Therapeutics, Inc. COO Sell 47.5 -10,090 -3.36% ✗ $8.2K
Feb 28, 2022 Mar 2, 2022 Akebia Therapeutics, Inc. COO Sell 78.8 +28,467 1.99% ✗ $46.6K
Apr 1, 2021 Apr 1, 2021 Akebia Therapeutics, Inc. COO Sell 52.5 -1,211 -0.45% ✗ $4.1K
Feb 26, 2021 Mar 2, 2021 Akebia Therapeutics, Inc. COO Sell 91.3 +47,453 22.85% ✗ $49.4K
Feb 28, 2020 Mar 2, 2020 Akebia Therapeutics, Inc. COO Sell 95.0 +58,028 39.49% ✗ $60.7K
Apr 11, 2019 Apr 12, 2019 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 22.5 -11,909 -7.50% ✗ $91.7K
Dec 12, 2018 Dec 13, 2018 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 22.5 -23,385 -19.95% ✗ $209.1K
Oct 2, 2017 Oct 4, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 48.8 -1,398 -1.44% ✓ $27.5K
Sep 28, 2017 Oct 2, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 37.5 -5,000 -4.89% ✓ $96.5K
Aug 15, 2017 Aug 17, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 37.5 -5,000 -4.66% ✓ $75K
Jul 3, 2017 Jul 6, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,399 -1.29% ✗ $19.9K
Apr 3, 2017 Apr 4, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,401 -1.27% ✗ $12.9K
Jan 1, 2017 Jan 3, 2017 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,629 -2.26% ✗ $17.1K
Oct 1, 2016 Oct 4, 2016 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,401 -1.90% ✗ $12.5K
Jul 5, 2016 Jul 6, 2016 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,402 -1.87% ✗ $10.5K
Apr 4, 2016 Apr 5, 2016 Akebia Therapeutics, Inc. SVP, Chief Business Officer Sell 26.3 -1,401 -1.83% ✗ $13.2K